The AIMS Clinic Model: A Retrospective Analysis of Interdisciplinary Movement-Neuropalliative Care for People With Late-Stage Parkinsonism.

IF 3.7 Q3 CLINICAL NEUROLOGY
Neurology. Clinical practice Pub Date : 2026-10-01 Epub Date: 2026-09-11 DOI:10.1212/CPJ.0000000000200652
Mariya Husain, Angela Hong, Marla E Tharp, Yuqing Chen, Aamina Naveed, Sarah Kee, Deepa H Shankar, Sarah Mitchell Chen, Grace Hong, Kristin A Gustashaw, Bichun Ouyang, Neha M Kramer, Jori E Fleisher
{"title":"The AIMS Clinic Model: A Retrospective Analysis of Interdisciplinary Movement-Neuropalliative Care for People With Late-Stage Parkinsonism.","authors":"Mariya Husain, Angela Hong, Marla E Tharp, Yuqing Chen, Aamina Naveed, Sarah Kee, Deepa H Shankar, Sarah Mitchell Chen, Grace Hong, Kristin A Gustashaw, Bichun Ouyang, Neha M Kramer, Jori E Fleisher","doi":"10.1212/CPJ.0000000000200652","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Patients with late-stage parkinsonism face complex, progressive symptoms requiring specialized interdisciplinary care, yet the unique needs of these patients and family care partners are often inadequately addressed in standard neurology practice. Evidence supporting innovative palliative care models for late-stage movement disorders remains limited. Although interdisciplinary movement-palliative clinics have expanded over the past decade, many provide consultation-only services, lack longitudinal follow-up, meet infrequently, or face sustainability challenges. We describe the Advanced Interdisciplinary Movement Disorders Supportive Care (AIMS) clinic, established in 2019, which delivers both consultative and longitudinal follow-up care tailored to meet the unique needs of this patient population.</p><p><strong>Methods: </strong>We describe the structure, workflow, and services of the AIMS clinic and present a retrospective review of patients seen between 2019 and 2023. Charts were systematically revied with relevant data extracted from documentation by the team, comprised of a movement disorders neurologist and fellows, neuropalliative care specialist, social worker, dietitian, and nurse. Data analyzed included demographics, initial and revised diagnoses, quality-of-life measures, morbidity, place of death, and hospice utilization at the time of death.</p><p><strong>Results: </strong>Among 175 consecutive patients seen between 2019 and 2023 (568 total visits), 78.7% were White; 57.7% male, with an average age of 72.8 (SD 11.9) years; and 97.5% were accompanied by a care partner. The most common diagnoses were Parkinson disease (42.3%), dementia with Lewy bodies (17.1%), and multiple system atrophy (12.6%). The median time from symptom onset to initial AIMS clinic visit was 7 years (range 1.0-31.0). Among 58 deceased patients, 40 (69.0%) were enrolled in hospice at the time of death.</p><p><strong>Discussion: </strong>This clinic highlights the feasibility and value of a longitudinal, outpatient interdisciplinary movement-neuropalliative care model for individuals living with late-stage parkinsonism-a group that is frequently lost to follow-up in traditional care pathways. Nearly 200 patients with late-stage disease were engaged in sustained care, and hospice utilization at the time of death substantially exceeded rates reported in usual care. Forthcoming analyses of symptom burden, quality-of-life trajectories, and end-of-life care will further inform best practices for comprehensive management in late-stage parkinsonism care.</p>","PeriodicalId":19136,"journal":{"name":"Neurology. Clinical practice","volume":"16 5","pages":"e200652"},"PeriodicalIF":3.7000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13574323/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology. Clinical practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1212/CPJ.0000000000200652","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/11 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objectives: Patients with late-stage parkinsonism face complex, progressive symptoms requiring specialized interdisciplinary care, yet the unique needs of these patients and family care partners are often inadequately addressed in standard neurology practice. Evidence supporting innovative palliative care models for late-stage movement disorders remains limited. Although interdisciplinary movement-palliative clinics have expanded over the past decade, many provide consultation-only services, lack longitudinal follow-up, meet infrequently, or face sustainability challenges. We describe the Advanced Interdisciplinary Movement Disorders Supportive Care (AIMS) clinic, established in 2019, which delivers both consultative and longitudinal follow-up care tailored to meet the unique needs of this patient population.

Methods: We describe the structure, workflow, and services of the AIMS clinic and present a retrospective review of patients seen between 2019 and 2023. Charts were systematically revied with relevant data extracted from documentation by the team, comprised of a movement disorders neurologist and fellows, neuropalliative care specialist, social worker, dietitian, and nurse. Data analyzed included demographics, initial and revised diagnoses, quality-of-life measures, morbidity, place of death, and hospice utilization at the time of death.

Results: Among 175 consecutive patients seen between 2019 and 2023 (568 total visits), 78.7% were White; 57.7% male, with an average age of 72.8 (SD 11.9) years; and 97.5% were accompanied by a care partner. The most common diagnoses were Parkinson disease (42.3%), dementia with Lewy bodies (17.1%), and multiple system atrophy (12.6%). The median time from symptom onset to initial AIMS clinic visit was 7 years (range 1.0-31.0). Among 58 deceased patients, 40 (69.0%) were enrolled in hospice at the time of death.

Discussion: This clinic highlights the feasibility and value of a longitudinal, outpatient interdisciplinary movement-neuropalliative care model for individuals living with late-stage parkinsonism-a group that is frequently lost to follow-up in traditional care pathways. Nearly 200 patients with late-stage disease were engaged in sustained care, and hospice utilization at the time of death substantially exceeded rates reported in usual care. Forthcoming analyses of symptom burden, quality-of-life trajectories, and end-of-life care will further inform best practices for comprehensive management in late-stage parkinsonism care.

AIMS临床模式:对晚期帕金森病患者跨学科运动-神经姑息治疗的回顾性分析。
背景和目的:晚期帕金森患者面临复杂的进行性症状,需要专门的跨学科护理,然而这些患者和家庭护理伙伴的独特需求在标准神经病学实践中往往得不到充分解决。支持晚期运动障碍创新姑息治疗模式的证据仍然有限。虽然跨学科的运动缓和诊所在过去的十年中已经扩大,但许多只提供咨询服务,缺乏纵向随访,很少见面,或面临可持续性挑战。我们描述了成立于2019年的高级跨学科运动障碍支持护理(AIMS)诊所,该诊所提供咨询和纵向随访护理,以满足这一患者群体的独特需求。方法:我们描述了AIMS诊所的结构、工作流程和服务,并对2019年至2023年期间就诊的患者进行了回顾性回顾。由运动障碍神经科医生及其同事、神经姑息治疗专家、社会工作者、营养师和护士组成的团队系统地审查了图表,并从文件中提取了相关数据。分析的数据包括人口统计、初始诊断和修订诊断、生活质量测量、发病率、死亡地点和死亡时的临终关怀利用。结果:在2019年至2023年期间连续就诊的175例患者(总就诊次数568次)中,78.7%为白人;男性57.7%,平均年龄72.8岁(SD 11.9);97.5%的人有护理伴侣陪伴。最常见的诊断是帕金森病(42.3%)、路易体痴呆(17.1%)和多系统萎缩(12.6%)。从症状出现到首次临床访问的中位时间为7年(范围1.0-31.0)。在58名死亡患者中,40名(69.0%)在死亡时参加了临终关怀。讨论:该诊所强调了纵向、门诊跨学科运动的可行性和价值,即针对晚期帕金森患者的神经姑息治疗模式,这一群体在传统的护理途径中经常失去随访。近200名晚期疾病患者接受了持续护理,临终关怀的使用率在死亡时大大超过了常规护理的使用率。即将进行的症状负担、生活质量轨迹和临终关怀的分析将进一步为晚期帕金森病护理的综合管理提供最佳实践。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neurology. Clinical practice
Neurology. Clinical practice CLINICAL NEUROLOGY-
CiteScore
4.00
自引率
0.00%
发文量
77
期刊介绍: Neurology® Genetics is an online open access journal publishing peer-reviewed reports in the field of neurogenetics. The journal publishes original articles in all areas of neurogenetics including rare and common genetic variations, genotype-phenotype correlations, outlier phenotypes as a result of mutations in known disease genes, and genetic variations with a putative link to diseases. Articles include studies reporting on genetic disease risk, pharmacogenomics, and results of gene-based clinical trials (viral, ASO, etc.). Genetically engineered model systems are not a primary focus of Neurology® Genetics, but studies using model systems for treatment trials, including well-powered studies reporting negative results, are welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书